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General Information.  Commercial reagents were purified prior to use following
the guidelines of Perrin and Armarego.1 Organic solutions were concentrated under
reduced pressure on a Büchi rotary evaporator.  Chloroform was distilled from calcium
hydride prior to use.  Ethyl acetate was pre-dried with 4Å molecular sieves prior to use.
Chromatographic purification of products was accomplished using forced-flow
chromatography on Iatrobeads 6RS –8060 according to the method of Still.2 Thin-layer
chromatography (TLC) was performed on EM Reagents 0.25 mm silica gel 60-F plates.
Visualization of the developed chromatogram was performed by fluorescence quenching,
KMnO4 or p-anisaldehyde stain.
1H and 13C NMR spectra were recorded on Varian Mercury 300 (300 MHz and 75
MHz respectively) as noted, and are internally referenced to residual protio solvent
signals.  Data for 1H are reported as follows: chemical shift (δ ppm), multiplicity (s =
singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant
(Hz) and assignment.  Data for 13C NMR are reported in terms of chemical shift.  IR
spectra were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in
terms of frequency of absorption (cm-1).  Mass spectra were obtained from the California
Institute of Technology Mass Spectral facility.   Gas liquid chromatography (GLC) was
performed on Hewlett-Packard 6850 Series gas chromatography equipped with a split-
mode capillary injection system and flame ionization detectors using a Bodman
Chiraldex Γ-TA (30 m 0.25 mm) or β-DM (30 m 0.25 mm) column. High performance
liquid chromatography (HPLC) was performed on Hewlett-Packard 1100 Series
chromatographs using Chiralcel AD column (1.6 x 25 cm) and AD guard (1.6 x 5 cm),
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Chiralcel OD−H (1.6 x 25 cm) and OD guard (1.6 x 5 cm), or Chiralcel AS (1.6 x 25 cm)
and AS guard (1.6 x 5 cm) as noted.
General Procedure:  To a 2-dram vial equipped with a magnetic stir bar and
charged with (2S, 5S)-5-(1-benzyl-1H-indol-3-yl)-2-tert-butyl-3-methyl-imidazolidin-4-
one (0.05 mmol) was added ethyl acetate (0.25 mL) and trifluoroacetic acid (0.05 mmol),
and then it was placed in a bath at the indicated temperature.  The solution was stirred for
5 min before addition of aldehyde (0.75 mmol) followed by the nucleophile (0.25 mmol)
and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one (0.5 mmol).  The resulting solution
was stirred at constant temperature until the reaction was determined to be complete by
TLC or GLC analysis.  The reaction was quenched by filtration through Iatrobeads
eluting with ethyl ether, and concentrated in vacuo under an ice bath.  The
diastereoselectivity was determined by 1H-NMR or GLC analysis.  The resulting residue
was purified by Iatrobeads chromatography (solvents noted) and fractions carefully
concentrated in vacuo under an ice bath to provide the title compounds.  The
enantioselectivity was determined by chiral GLC or HPLC analysis.
(2R,3S)-2-Chloro-3-(5-methyl-furan-2-yl)-butyraldehyde (Table 2, entry 1):
Prepared according to the general procedure from 2-methyl furan (22.6 µL, 0.25 mmol),
crotonaldehyde (62 µL, 0.75 mmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one
(150 mg, 0.5 mmol) for 36 h to provide the title compound as a colorless oil (40.2 mg,
86% yield, 14:1 dr, 99% ee) after Iatrobeads chromatography (3% ethyl ether/ pentane).
IR (film) 2982, 2924, 1733, 1567, 1455, 1383, 1218 cm-1; 1H NMR (300 MHz, CDCl3) δ
9.49 (d, 1H, J = 2.75 Hz CHO), 6.02 (d, 1H, J = 2.75 Hz, CCHCH), 5.88 (dq, 1H, J =
2.76, 1.10 Hz, CCHCH), 4.40 (dd, 1H, J = 2.75, 5.5 Hz, ClCHCHO), 3.52 (penta, 1H, J
= 6.60, CH3CHCHCl), 2.25 (d, 3H, J = 1.10, COCH3), 1.35 (d, J = 7.8 Hz, 3H, CHCH3);
13C NMR (75 MHz, CDCl3) δ 194.65, 152.00, 151.65, 107.68, 106.18, 66.98, 35.66,
14.14, 13.53; HRMS (CI) exact mass calculated for (C9H10ClO2) requires m/z 185.0369,
found m/z 185.0373.  [α ]D = +48.4 (c = 1.35, CH2Cl2). The diastereomeric and
enantiomeric ratio was determined by GLC using a Bodman Chiraldex β−DM (30 m x
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0.25 mm) column (100 °C isotherm, 1 mL/min);  (2S, 3R) isomer tr = 20.6 min, (2R, 3S)
isomer tr = 20.8 min, (2R, 3R) isomer tr = 22.0 min, (2S, 3S) isomer tr = 22.9 min.
(2R,3S)-2-Chloro-3-(5-methyl-furan-2-yl)-hexanal (Table 2, entry 2):
Prepared according to the general procedure from 2-methyl furan (22.6 µL, 0.25 mmol),
2-hexenal (87 µL, 0.75 mmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one (150
mg, 0.5 mmol) for 60 h to provide the title compound as a colorless oil (39.7 mg, 74%
yield, 13:1 dr, 99% ee) after Iatrobeads chromatography (3% ethyl ether/ pentane).  IR
(film) 2960, 2932, 1733, 1694, 1581, 1561, 1218, 1112 cm-1; 1H NMR (300 MHz, CDCl3)
δ 9.38 (d, 1H, J = 3.30 Hz CHO), 6.03 (d, 1H, J = 3.03 Hz, CCHCH), 5.87 (m, 1H,
CCHCH), 4.29 (dd, 1H, J = 3.30, 6.60 Hz, ClCHCHO), 3.28 (q, 1H, J = 7.32,
CH2CHCHCl), 2.24 (d, 3H, J = 1.10, COCH3), 1.77 (dt, 2H, J = 6.60, 7.98 Hz,
CH2CH2CH3), 1.26 (m, 2H, CH2CH2CH3), 0.90 (t, 3H, J = 8.43, CH2CH2CH3); 13C NMR
(75 MHz, CDCl3) δ 194.19, 151.82, 150.29, 108.95, 106.16, 66.03, 41.82, 31.99, 20.29,
13.80, 13.57; HRMS (CI) exact mass calculated for (C11H15ClO2) requires m/z 214.0761,
found m/z 214.0767.  [α ]D = +17.5 (c = 1.25, CH2Cl2). The diastereomeric and
enantiomeric ratio was determined by GLC using a Bodman Chiraldex Γ−TA (30 m x
0.25 mm) column (80 °C isotherm, 1 mL/min);  (2R, 3S) isomer tr = 68.2 min, (2S, 3R)
isomer tr = 70.8 min, (2S, 3S) isomer tr = 77.8 min, (2R, 3R) isomer tr = 86.4 min.
(2R,3S)-3-Chloro-2-(5-methyl-furan-2-yl)-4-oxo-butyric acid methyl ester
(Table 2, entry 3): Prepared according to the general procedure from 2-methyl furan
(22.6 µL, 0.25 mmol), trans-4-oxo-but-2-enoic acid methyl ester (34 mg, 0.3 mmol) and
2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one (90 mg, 0.3 mmol) for 36 h to provide
the title compound as a colorless oil (48.9 mg, 80% yield, 22:1 dr, >99% ee) after
Iatrobeads chromatography (10% ethyl acetate/ hexanes).  IR (film) 2956, 2925, 1739,
1560, 1437, 1232, 1163 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.53 (d, 1H, J = 2.39 Hz
CHO), 6.27 (d, 1H, J = 3.19 Hz, CCHCH), 5.97 (m, 1H, CCHCH), 4.75 (dd, 1H, J =
7.97, 2.39 Hz, ClCHCHO), 4.43 (d, 1H, J = 7.97, CHCO2CH3), 3.81 (s, 3H, CO2CH3),
2.92 (s, 3H, COCH3); 13C NMR (75 MHz, CDCl3) δ 192.33, 168.34, 153.04, 144.32,
110.71, 106.84, 61.27, 53.00, 48.50, 13.54; HRMS (CI) exact mass calculated for
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(C10H11ClO4) requires m/z 230.0346, found m/z 230.0339.  [α]D = –27.9 (c = 1.27,
CH2Cl2). The diastereomeric and enantiomeric ratio was determined by GLC using a
Bodman Chiraldex Γ−TA (30 m x 0.25 mm) column (100 °C isotherm, 25 min, ramp to
180 °C via 5 °C/min, 1 mL/min);  (2S, 3R) isomer tr = 35.1 min, (2R, 3S) isomer tr = 35.3
min, (2R, 3R) isomer tr = 36.2 min, (2S, 3S) isomer tr = 36.5 min.
(2R,3S)-Acetic acid 3-chloro-2-(5-methyl-furan-2-yl)-4-oxo-butyl ester (Table
2, entry 4): Prepared according to the general procedure from 2-methyl furan (22.6 µL,
0.25 mmol), acetic acid 4-oxo-but-2-enyl ester (51.3 mg, 0.4 mmol) and 2,3,4,5,6,6-
hexachloro-2,4-cyclohexadien-1-one (120 mg, 0.4 mmol) for 18 h to provide the title
compound as a colorless oil (50.2 mg, 82% yield, 11:1 dr, >99% ee) after Iatrobeads
chromatography (10% ethyl acetate/ hexanes).  IR (film) 2924, 2853, 1743, 1368, 1232,
1042 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.56 (d, 1H, J = 2.12 Hz CHO), 6.14 (d, 1H, J
= 4.09 Hz, CCHCH), 5.94 (m, 1H, CCHCH ), 4.57 (dd, 1H, J = 5.05, 2.12 Hz,
ClCHCHO), 4.48 (m, 2H, CH2O), 3.88 (m, 1H, CHCH2O), 2.29 (s, 3H, COCH3), 2.07 (s,
3H, OCOCH3); 13C NMR (75 MHz, CDCl3) δ 194.31, 170.20, 152.26, 147.28, 109.04,
106.43, 63.87, 61.58, 41.07, 20.76, 13.50; HRMS (CI) exact mass calculated for
(C11H13ClO4) requires m/z 244.0502, found m/z 244.0494.  [α]D = +24.3 (c = 1.10,
CH2Cl2). The diastereomeric and enantiomeric ratio was determined by GLC analysis of a
bis-trifluoroacetate derivative (DIBAL reduction, followed by bis-trifluoroacetylation)
using a Bodman Chiraldex Γ−TA (30 m x 0.25 mm) column (100 °C isotherm, 60 min, 1
mL/min);  (2R, 3S) isomer tr = 39.8 min, (2S, 3S) isomer tr = 40.6 min, (2S, 3R) isomer tr
= 42.0 min, (2R, 3R) isomer tr = 44.0 min.
(2R,3S)-2-Chloro-3-(1-methyl-1H-indol-3-yl)-3-phenyl-propionaldehyde
(Table 2, entry 5): Prepared according to the general procedure from 1-methyl indole
(32 µL, 0.25 mmol), trans-cinnamaldehyde (50.4 µL, 0.4 mmol) and 2,3,4,5,6,6-
hexachloro-2,4-cyclohexadien-1-one (120 mg, 0.4 mmol) for 36 h to provide the title
compound as a colorless oil (61.8 mg, 83% yield, 9:1 dr, 99% ee) after Iatrobeads
chromatography (15% ethyl acetate/ hexanes).  IR (film) 3058, 2932, 2826, 1732, 1674,
1474, 1454, 1373, 1332 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.36 (d, 1H, J = 3.30 Hz
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CHO), 7.38 (m, 8H, PhH  and IndH), 7.07 (m, 2H, PhH  and IndH), 4.81 (m, 2H,
ClCHCHO and IndCHPh), 3,76 (s, 3H, NCH3); 13C NMR (75 MHz, CDCl3) δ 193.14,
139.27, 136.82, 128.66, 128.51, 127.28, 126.95, 122.25, 119.51, 118.85, 112.64, 109.43,
65.91, 45.09, 32.90; HRMS (CI) exact mass calculated for (C18H16ClNO) requires m/z
297.0920, found m/z 297.0923.  [α]D = +5.8 (c = 0.62, CH2Cl2). The diastereomeric ratio
was determined by NMR.  The enantiomeric ratio was determined by HPLC of the
NaBH4 reduced alcohol using a Chiracel AD and AD guard column (8% i-propanol/
hexanes, 1 mL/min);  (2S, 3R) isomer tr = 15.9 min, (2S, 3S) isomer tr = 18.0 min, (2R,
3S) isomer tr = 20.3 min, (2R, 3R) isomer tr = 22.0 min.
(2R,3S)-2-Chloro-4-methyl-3-(1-methyl-1H-indol-3-yl)-pentanal (Table 2,
entry 6): Prepared according to the general procedure from 1-methyl indole (32 µL, 0.25
mmol), trans-4-methyl-pent-2-enal (46.5 µL, 0.4 mmol) and 2,3,4,5,6,6-hexachloro-2,4-
cyclohexadien-1-one (120 mg, 0.4 mmol) for 24 h to provide the title compound as a
colorless oil (44.2 mg, 67% yield, 12:1 dr, >99% ee) after Iatrobeads chromatography
(6% ethyl acetate/ hexanes).  IR (film) 3058, 2932, 2826, 1732, 1674, 1474, 1454, 1373,
1332 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.18 (d, 1H, J = 5.52 Hz CHO), 7.62 (dt, 1H, J
= 7.97, 1.07 Hz, IndH), 7.29 (m, 1H, IndH), 7.16 (m, 1H, IndH), 6.88 (s, 1H, IndH), 4.47
(dd, 1H, J = 9.83, 4.26 Hz, ClCHCHO), 3.81 (s, 3H, NCH3) 3.50 (dd, 1H, J = 9.57, 5.31
Hz, CHCHClCHO), 2.55 (m, 1H, CH(CH3)2), 0.94 (d, 6H, J = 6.91 Hz, CH(CH3)2); 13C
NMR (75 MHz, CDCl3) δ 193.47, 136.57, 128.41, 127.80, 122.00, 119.42, 119.08,
109.62, 109.36, 65.36, 44.51, 32.96, 28.31, 21.70, 17.70; HRMS (CI) exact mass
calculated for (C15H18ClNO) requires m/z 263.1077, found m/z 263.1069.  [α]D = +11.3 (c
= 0.80, CH2Cl2).  The diastereomeric ratio was determined by NMR.  The enantiomeric
ratio was determined by HPLC of the NaBH4 reduced alcohol using a Chiracel AD and
AD guard column (5% i-propanol/ hexanes, 1 mL/min);  (2S, 3S) isomer tr = 17.8 min,
(2S, 3R) isomer tr = 20.7 min, (2R, 3S) isomer tr = 22.5 min, (2R, 3R) isomer tr = 29.1
min.
(2R,3S)-2-Chloro-3-(5-methoxy-thiophen-2-yl)-butyraldehyde (Table 3, entry
2): Prepared according to the general procedure from 2-methoxy thiophene (25 µL, 0.25
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mmol), crotonaldehyde (62 µL, 0.75 mmol) and 2,3,4,5,6,6-hexachloro-2,4-
cyclohexadien-1-one (150 mg, 0.5 mmol) for 36 h to provide the title compound as a
colorless oil (42.1 mg, 77% yield, 11:1 dr, 99% ee) after Iatrobeads chromatography
(10% ethyl ether/ pentane).  IR (film) 2927, 2852, 1732, 1560, 1505, 1431, 1379, 1207
cm-1; 1H NMR (300 MHz, CDCl3) δ 9.43 (d, 1H, J = 3.03 Hz CHO), 6.51 (dd, 1H, J =
3.85, 0.82 Hz, SCCHCH), 6.01 (d, 1H, J = 3.85 Hz, SCCHCH), 4.23 (dd, 1H, J = 6.32,
3.02 Hz, ClCHCHO), 3.85 (s, 3H, CH3O), 3.58 (penta, 1H, J = 6.88 Hz, CH3CHCHCl),
1.41 (d, 3H, J = 6.88 Hz, CHCH3); 13C NMR (75 MHz, CDCl3) δ 194.27, 165.48, 129.72,
122.63, 103.03, 68.70, 60.21, 37.88, 17.89; HRMS (CI) exact mass calculated for
(C9H11ClO2S) requires m/z 218.0168, found m/z 218.0159.  [α]D = –3.4 (c = 2.17,
CH2Cl2). The diastereomeric and enantiomeric ratio was determined by GLC using a
Bodman Chiraldex Γ−TA (30 m x 0.25 mm) column (120 °C isotherm, 1 mL/min);  (2R,
3R) isomer tr = 27.5 min, (2S, 3S) isomer tr = 27.9 min, (2S, 3R) isomer tr = 28.6 min,
(2R, 3S) isomer tr = 29.4 min.
 (2R,3S)-2-Chloro-3-((2S)-2-methyl-5-oxo-2,5-dihydro-furan-2-yl)-
butyraldehyde (Table 3, entry 3): Prepared via a sequential addition fashion: To a 2
dram vial equipped with a magnetic stir bar and charged with (2S, 5S)-5-(1-benzyl-1H-
indol-3-yl)-2-tert-butyl-3-methyl-imidazolidin-4-one (18.1 mg, 0.05 mmol) and
trifluoroacetic acid (3.85 µL, 0.05 mmol), ethyl acetate (0.25 mL) was added and the
solution cooled to –55 °C.  The solution was cooled for 5 minutes and crotonaldehyde
(41.4 µL, 0.5 mmol) was added in one portion followed by trimethyl-(5-methyl-furan-2-
yloxy)-silane (46 µL, 0.25 mmol).  The mixture was stirred for 24 hours and 2,3,4,5,6,6-
hexachloro-2,4-cyclohexadien-1-one (150 mg, 0.5 mmol) was added.  The resulting
solution was stirred until reaction is determined to be complete by TLC.  The reaction
was quenched by filtration through Iatrobeads (8 g) eluting with ethyl ether, and carefully
concentrated in vacuo with an ice bath.  The resulting residue is purified by Iatrobeads
chromatography (20% ethyl acetate/ hexanes) to provide the title compound as a colorless
oil (36 mg, 71% yield, >25:1 dr, >99% ee).  IR (film) 2986, 1754, 1603, 1452, 1378,
1228, 1126, 1099, 953 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.44 (d, 1H, J = 0.55 Hz,
CHO), 7.50 (d, 1H, J = 5.78 Hz, CH=CHC=O), 6.06 (d, 1H, J = 5.78 Hz, CH=CHC=O),
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4.30 (dd, 1H, J = 2.21, 0.55 Hz, ClCHCHO), 2.93 (dq, 1H, J = 2.20, 6.88 Hz, CHCHCl),
1.53 (s, 3H, CH3CO), 1.07 (d, 3H, J = 6.88 Hz, CH3CHCl); 13C NMR (75 MHz, CDCl3) δ
194.44, 171.62, 158.55, 121.17, 89.25, 63.92, 41.38, 24.07, 21.08, 11.28; HRMS (CI)
exact mass calculated for (C9H11ClO3) requires m/z 202.0397, found m/z 202.0386.  [α]D
= +114.4 (c = 1.04, CH2Cl2). NMR showed only one of the four possible diastereomers.
The enantiomeric ratio was determined by GLC analysis using a Bodman Chiraldex
Γ−TA (30 m x 0.25 mm) column (150 °C isotherm, 1 mL/min); minor enantiomer tr =
29.2 min, major enantiomer tr = 32.2 min.
(2R,3S)-3-(1-Benzyl-1H-indol-3-yl)-2-chloro-butyraldehyde (Table 3, entry
4): Prepared according to the general procedure from 1-benzyl indole (52 mg, 0.25
mmol), crotonaldehyde (25 µL, 0.3 mmol) and 2,3,4,5,6,6-hexachloro-2,4-
cyclohexadien-1-one (90 mg, 0.3 mmol) for 48 h. The desired product was isolated as the
corresponding alcohol after NaBH4 reduction (58.8 mg, 75% yield, 9:1 dr, >99% ee) after
silica gel chromatography (20% ethyl acetate/ hexanes).  IR (film) 3381, 2972, 2934,
1467, 1454, 1376, 1355, 1178 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.63 (dt, 1H, J = 8.25,
1.37 Hz, IndH), 7.17 (m, 8H, PhH and IndH), 7.00 (s, 1H, IndH), 5.29 (s, 2H, CH2Ph),
4.30 (ddd, 1H, J = 6.88, 8.25, 3.85 Hz, ClCHCHO), 3.69 (m, 2H, CHClCH2OH), 3.46
(penta, 3H, J = 6.88 Hz, CH3CHCHCl), 1.56 (d, 3H, J = 6.88 Hz, CHCH3); 13C NMR (75
MHz, CDCl3) δ 137.42, 136.68, 128.83, 127.87, 126.96, 126.69, 125.72, 122.09, 119.39,
119.27, 116.96, 110.00, 70.83, 65.95, 50.04, 34.61, 18.69; HRMS (CI) exact mass
calculated for (C19H20ClNO) requires m/z 313.1233, found m/z 313.1225.  [α]D = +9.3 (c
= 0.79, CH2Cl2). The diastereomeric and enantiomeric ratio was determined by HPLC of
the corresponding alcohol after NaBH4 reduction using a Chiracel AD and AD guard
column (2.5% i-propanol/ hexanes, 1 mL/min);  (2S, 3S) isomer tr = 80.6 min, (2S, 3R)
isomer tr = 89.0 min, (2R, 3R) isomer tr = 92.4 min, (2R, 3S) isomer tr = 97.6 min.
(2R,3S)-2-chloro-3-((S)-4,5-dihydro-4-methyl-5-oxo-2-phenyloxazol-4-
yl)butanal (Table 3, entry 5).3  To a 1-dram vial equipped with a magnetic stir bar and
charged with (2R)-2-tert-butyl-3-methyl-imidazolidin-4-one TCA salt (16 mg, 0.05
mmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one (300 mg, 1.0 mmol),
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acetonitrile (1.0 mL) and H2O (9 µL, 0.5 mmol) were added.  The vial was cooled
immediately to –40 °C.  After 3 minutes, crotonaldehyde (124 µL, 1.5 mmol) and 4-
methyl-2-phenyl-5-triisopropylsilanyloxy-oxazole (0.166 g, 0.50 mmol) were added via
syringe.  After 4 h, the reaction was flushed though an Iatrobeads plug with Et2O and
concentrated. The title compound was isolated as the hydrate in 75% yield (0.112 g, 0.38
mmol) after chromatography on Iatrobeads (0-2-4-7% Et2O/hex to 4:11:85 to 4:13:83
EtOAc/Et2O/hex); 9:1 syn:anti, 99% ee.  Product ratios were determined by GLC
(Bodman Γ-TA column, 140 °C, 20 min; 1 °C/min gradient, 145 °C, 20 min; 1 °C/min
gradient, 150 °C, 20 min 23 psi); (2R, 3S) syn isomer tr =  59.9 min, (2S, 3R) syn isomer tr
=  62.7 min, anti isomers t = 64.0 min.  IR (film) 3045, 2939, 1822, 1724, 1654, 1004
cm–1; 1H NMR (300 MHz, CDCl3) δ 7.76 (m, 2H, ArH), 7.43 (m, 3H, ArH), 5.26 (d, J =
4.1 Hz, 1H, CH(OH)2, 4.34 (dd, J = 4.1, 9.2 Hz, 1H, CHCl), 2.77 (m, 1H, CHCH3), 2.06
(s, 3H, CH3), 1.40 (d, J = 7.2 Hz, 3H, CHCH3).  13C NMR (300 MHz, CDCl3) δ 202.8,
182.7, 163.6, 135.0, 131.2, 128.5, 128.0, 82.1, 70.2, 62.4, 48.3, 23.3, 11.2; HRMS (FAB)
exact mass calcd for (C14H15ClNO3) requires m/z 280.0744, found m/z 280.0744;  [αD] =
–2.1 (c = 1.0, CHCl3).
(2S,3R)-2-Chloro-3-phenyl-butyraldehyde (Equation 3): To a 2 dram vial
equipped with a magnetic stir bar and charged with (2R )-2-tert-butyl-3-methyl-
imidazolidin-4-one TCA salt (16 mg, 0.05 mmol), chloroform (1 mL) was added 3-
phenyl-but-2-enal (36.5 mg, 0.25 mmol), and the solution cooled to the –40 °C.  The
solution was cooled for 5 minutes and di-tert-butyl 1,4-dihydro-2,6-dimethylpyridine-
3,5-dicarboxylate (92.2 mg, 0.3 mmol) was added in one portion.  The mixture was
stirred for 24 hours and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one (150 mg, 0.5
mmol) was added in one portion.  The resulting solution was stirred until the reaction is
determined to be complete by TLC.  The reaction was quenched by filtration through
Iatrobeads (8 g) eluting with ethyl ether, and carefully concentrated in vacuo with an ice
bath.  The resulting residue is purified by Iatrobeads chromatography (3% ethyl ether/
pentane) to provide the title compound as a colorless oil (25.6 mg, 70% yield, 8:1 dr,
99% ee).  The product was analyzed according to reported procedure, and its spectral data
match the literature values.4
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(2R, 3R)-2-Chloro-3-phenyl-butyraldehyde (Equation 4): To a 2 dram vial
equipped with a magnetic stir bar and charged with (2R )-2-tert-butyl-3-methyl-
imidazolidin-4-one TCA salt (16 mg, 0.05 mmol), chloroform (1 mL) was added 3-
phenyl-but-2-enal (36.5 mg, 0.25 mmol), and the solution cooled to the –20 °C.  The
solution was cooled for 5 minutes and di-tert-butyl 1,4-dihydro-2,6-dimethylpyridine-
3,5-dicarboxylate (92.2 mg, 0.3 mmol) was added in one portion.  The mixture was
stirred for 24 hours and N-fluorobenzenesulfonamide (0.394 g, 1.25 mmol) was added in
one portion followed by THF:iPrOH (9:1) (1.25 mL).  The resulting solution was stirred
until the reaction is determined to be complete by TLC (30 h).  The reaction was cooled
to –78 °C, diluted with Et2O and filtered through a pad of Davisil® Silica Gel, eluting
with Et2O and concentrated in vacuo.  The reaction was dissolved in Et2O and Me2S was
added forming a white precipitate.  The resulting mixture was washed with sat. NaHCO3,
dried over MgSO4, filtered and concentrated in vacuo.  Enantiomeric and diastereomeric
ratios were determined by GLC (1:3 dr, 99% ee) using a CP-Chirasil-Dex-CB (50 m x
0.25 mm) column (90 °C isotherm);  (2S, 3R) anti isomer tr =  40.1 min, (2R, 3S) anti
isomer tr =  37.3 min, (2R, 3R) syn isomer tr =  36.1 min, (2R, 3R) syn isomer tr =  35.0
min. The resulting aldehyde was taken up in EtOH (5 mL) and NaBH4 (58.3 mg, 1.54
mmol) was added.  The reaction was allowed to stir for 1 hour, then quenched with H2O,
and basified to pH 12-13 and extracted with Et2O.  The combined organic extracts were
dried over MgSO4, filtered and concentrated in vacuo.  Purification on silica gel (10-50%
Et2O/pentane) afforded (2R,3R)-2-fluoro-3-phenylbutan-1-ol as a colorless liquid (25.1
mg, 60% yield).
(2S, 3R)-2-Fluoro-3-phenyl-butyraldehyde (Equation 5): To a 20 mL vial
equipped with a magnetic stir bar was added 3-phenyl-but-2-enal (45 mg, 0.31 mmol)
and di-tert-butyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate (114.3 mg, 0.37
mmol).  This mixture was dissolved in chloroform (0.25 mL) and cooled to –20 °C.
After stirring for 10 min, a solution of (2R)-2-tert-butyl-3-methyl-imidazolidin-4-one
TCA salt (7.4 mg, 23.1 µmol) in chloroform (0.25 mL) was added.  The reaction was
allowed to stir for 30 h then N-fluorobenzenesulfonamide (0.485 g, 1.54 mmol) was
added followed by a solution of (S)-5-benzyl-2,2,3,trimethylimidazolidin-4-one
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dichloroacetic acid salt (32.1 mg, 92.4 µmol) in THF:iPrOH (9:1) (1.25 mL).  The vial
was then placed in a –10 °C bath and allowed to stir for 12 h.  The reaction was cooled to
–78 °C, diluted with Et2O and filtered through a pad of Davisil® Silica Gel, eluting with
Et2O and concentrated in vacuo.  The reaction was dissolved in Et2O and Me2S was added
forming a white precipitate.  The resulting mixture was washed with sat. NaHCO3, dried
over MgSO4, filtered and concentrated in vacuo.  Enantiomeric and diastereomeric ratios
were determined by GLC (16:1 dr, 99% ee) using a CP-Chirasil-Dex-CB (50 m x 0.25
mm) column (90 °C isotherm);  (2S, 3R) anti isomer tr = 40.1 min, (2R, 3S) anti isomer tr
=  37.3 min, (2R, 3R) syn isomer tr =  36.1 min, (2R, 3R) syn isomer tr =  35.0 min.
The aldehyde product was taken up in EtOH (5 mL) and NaBH4 (58.3 mg, 1.54
mmol) was added.  The reaction was allowed to stir for 1 hour, then quenched with H2O,
and basified to pH 12-13 and extracted with Et2O.  The combined organic extracts were
dried over MgSO4, filtered and concentrated in vacuo.  Purification on silica gel (10-50%
Et2O/pentane) afforded (2S,3R)-2-fluoro-3-phenylbutan-1-ol as a colorless liquid (42.1
mg, 81% yield).  IR (film) 3367, 2934, 1494, 1453, 1021, 845, 762, 701 cm-1; 1H NMR
(300 MHz, CDCl3) δ  7.36-7.19 (m, 5H, ArH), 4.70-4.45 (dddd, 1H, J = 3.0, 6.0, 11.7,
48.9 Hz, FCH), 3.66-3.44 (m, 2H, CH2OH), 3.08 (ddq, 1H, J = 6.0, 11.7, 23.7 Hz,
CHCH3), 1.72 (bs, 1H, OH), 1.40 (d, 3H, J = 6.9 Hz, CH3); 13C NMR (75 MHz, CDCl3) δ
142.0 (d, J = 8.3 Hz), 128.8, 127.6, 127.0, 98.0 (d, J = 173.7 Hz), 63.4 (d, J = 21.7 Hz),
41.0, (d, J = 20.3 Hz), 17.4 (d, J = 4.6 Hz); HRMS (EI+) exact mass calculated for
(C10H13OF) requires m/z 168.0950, found m/z 168.0947.  [α]D = -15.1 (c = 1.0, CHCl3).
(2R, 3R)-2-Fluoro-3-phenyl-butyraldehyde (Equation 6): To a 20 mL vial
equipped with a magnetic stir bar was added 3-phenyl-but-2-enal (45 mg, 0.31 mmol)
and di-tert-butyl 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylate (114.3 mg, 0.37
mmol).  This mixture was taken up in chloroform (0.25 mL) and cooled to –20 °C.  After
stirring for 10 min, a solution of (2R)-2-tert-butyl-3-methyl-imidazolidin-4-one TCA salt
(7.4 mg, 23.1 µmol) in chloroform (0.25 mL) was added.  The reaction was allowed to
stir for 30 h then N-fluorobenzenesulfonamide (0.485 g, 1.54 mmol) was added followed
by a solution of (S)-5-benzyl-2,2,3,trimethylimidazolidin-4-one dichloroacetic acid salt
(32.1 mg, 92.4 µmol) in THF:iPrOH (9:1) (1.25 mL).  The vial was kept in the –20 °C
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bath and allowed to stir for 30 h.  The reaction was cooled to –78 °C, diluted with Et2O
and filtered through a pad of Davisil® Silica Gel, eluting with Et2O and concentrated in
vacuo.  The reaction was dissolved in Et2O and Me2S was added forming a white
precipitate.  The resulting mixture was washed with sat. NaHCO3, dried over MgSO4,
filtered and concentrated in vacuo.  Enantiomeric and diastereomeric ratios were
determined by GLC (1:9 dr, 99% ee) using a CP-Chirasil-Dex-CB (50 m x 0.25 mm)
column (90 °C isotherm);  (2S, 3R) anti isomer tr =  40.1 min, (2R, 3S) anti isomer tr =
37.3 min, (2R, 3R) syn isomer tr =  36.1 min, (2R, 3R) syn isomer tr =  35.0 min.
The resulting aldehyde was taken up in EtOH (5 mL) and NaBH4 (58.3 mg, 1.54
mmol) was added.  The reaction was allowed to stir for 1 hour, then quenched with H2O,
and basified to pH 12-13 and extracted with Et2O.  The combined organic extracts were
dried over MgSO4, filtered and concentrated in vacuo.  Purification on silica gel (10-50%
Et2O/pentane) afforded (2R,3R)-2-fluoro-3-phenylbutan-1-ol as a colorless liquid (32.1
mg, 62% yield).  IR (film) 3368, 2931, 1494, 1452, 1045, 853, 761, 700 cm-1; 1H NMR
(300 MHz, CDCl3) δ 7.36-7.20 (m, 5H, ArH), 4.78-4.56 (dtd, 1H, J = 3.0, 6.6, 48.6 Hz,
FCH), 3.80-3.60 (m, 2H, CH2OH), 3.08 (dquin, 1H, J = 7.2, 19.8 Hz, CHCH3), 1.75 (bs,
1H, OH), 1.35 (d, 3H, J = 7.5 Hz, CH3); 13C NMR (75 MHz, CDCl3) δ 142.0 (d, J = 8.3
Hz), 128.5, 127.9, 126.8, 97.0 (d, J = 172.6 Hz), 63.4 (d, J = 22.3 Hz), 40.9, (d, J = 19.4
Hz), 17.4 (d, J = 6.5 Hz); HRMS (EI+) exact mass calculated for (C10H13OF) requires m/z
168.0950, found m/z 168.0957.  [α]D = -1.07 (c = 0.8, CHCl3).
Absolute and relative configuration was assigned by chemical correlation by
derivatization to the known epoxide4:  ( S, S)-2-Methyl-5-(1-oxiranyl-ethyl)-furan:
Prepared via a one-pot fashion: To a 3 dram vial equipped with a magnetic stir bar and
charged with (2S, 5S)-5-(1-benzyl-1H-indol-3-yl)-2-tert-butyl-3-methyl-imidazolidin-4-
one (18.1 mg, 0.05 mmol) and trifluoroacetic acid (3.85 µL, 0.05 mmol), ethyl acetate
(0.25 mL) was added and the solution cooled to –40 °C.  The solution was cooled for 5
minutes and crotonaldehyde (124 µL, 1.5 mmol) was added in one portion followed by 2-
methyl furan (45 µL, 0.5 mmol) and 2,3,4,5,6,6-hexachloro-2,4-cyclohexadien-1-one
(301 mg, 1 mmol).  The resulting solution was stirred at –40 °C for 36 hours and was
diluted with ethanol (1 mL), followed by addition of NaBH4 (75.6 mg, 2 mmol).  The
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resulting white suspension was warmed to +4 °C and stirred for 20 minutes.  Aqueous
NaOH solution (50% w/w, 3 mL) was then added.  The bi-phase mixture was rigorously
stirred for 30 minutes.  The reaction was quenched with saturated aqueous NaHCO3
solution and extracted three times with dichloromethane.  The organic layers were
combined, dried and concentrate in vacuo with an ice bath.  The resulting residue is
purified by silica gel chromatography (solvents noted) and fractions carefully
concentrated in vacuo with an ice bath to provide the title compound (47.2 mg, 62%
yield, 99% ee).  The minor diastereomer structure was confirmed by comparison with
literature reported data.5  The major diastereomer structure was assigned accordingly.
[α]D = -29.0 (c = 1.35, CH2Cl2).
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